Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium chloride + sodium lactate + sodium chloride + dextrose monohydrate + calcium is a marketed intravenous crystalloid and carbohydrate combination solution corresponding to Lactated Ringer's and Dextrose and the potassium-containing presentation Potassium Chloride in Lactated Ringer's and Dextrose. It is used for parenteral fluid and electrolyte replacement and as a source of water, electrolytes, and calories, with sodium, potassium, calcium, chloride, lactate, and dextrose collectively restoring extracellular fluid composition and energy supply. Sodium lactate serves as an alkalinizing precursor because it is metabolized to bicarbonate, helping buffer metabolic acidosis, while dextrose provides carbohydrate calories and the electrolyte salts replenish deficits. Public labeling attributes these products to ICU Medical and Hospira, and the drug is administered as a single-dose intravenous injection solution in adults and pediatric patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium chloride + sodium lactate + sodium chloride + dextrose monohydrate + calcium.